Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy
Neetha Rajan Latha
1
,
Arathi Rajan
1
,
Revathy Nadhan
1
,
Sarada Achyutuni
1
,
Satheesh Kumar Sengodan
1
,
Sreelatha Krishnakumar Hemalatha
2, 3
,
Geetu Rose Varghese
1
,
Ratheeshkumar Thankappan
1
,
Neethu Krishnan
1
,
Dipyaman Patra
1
,
Arathy Warrier
1
,
Priya Srinivas
1
1
2
Publication type: Journal Article
Publication date: 2020-07-01
scimago Q1
wos Q1
SJR: 1.820
CiteScore: 10.4
Impact factor: 5.6
ISSN: 10408428, 18790461
PubMed ID:
32464482
Oncology
Hematology
Abstract
Breast Cancer is the most predominant female cancer in developed as well as developing countries. The treatment strategies of breast cancers depends on an array of factors like age at diagnosis, menstrual status, dietary pattern, immunological response, genetic variations of the cancer cells etc. Recent technological advancements in cancer diagnosis lead to the emergence of gene expression pattern for better understanding of the tumor behavior. It has not only bolstered the prognosis, but also the early diagnosis and therapy. The accuracy in disease prognosis can be boosted when gene expression signatures are combined with traditional clinicopathological features. This review explains how the evolution of gene expression signatures for breast cancers, its advantages and future prospects. In addition, an overview of currently available gene expression signature analysis tools and consolidated information on their current status and specific benefits, that can be availed for breast cancer diagnosis are also discussed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Frontiers in Oncology
2 publications, 6.25%
|
|
|
Current Cancer Therapy Reviews
1 publication, 3.13%
|
|
|
Journal of Ovarian Research
1 publication, 3.13%
|
|
|
Biomolecules
1 publication, 3.13%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.13%
|
|
|
Breast Cancer Research and Treatment
1 publication, 3.13%
|
|
|
Pathology Research and Practice
1 publication, 3.13%
|
|
|
Seminars in Cancer Biology
1 publication, 3.13%
|
|
|
Informatics in Medicine Unlocked
1 publication, 3.13%
|
|
|
Biochimie
1 publication, 3.13%
|
|
|
Critical Reviews in Oncology/Hematology
1 publication, 3.13%
|
|
|
Journal of Cellular and Molecular Medicine
1 publication, 3.13%
|
|
|
International Journal of Women's Health
1 publication, 3.13%
|
|
|
Disease Markers
1 publication, 3.13%
|
|
|
Studies in Computational Intelligence
1 publication, 3.13%
|
|
|
Clinical Breast Cancer
1 publication, 3.13%
|
|
|
Journal of Gastrointestinal Oncology
1 publication, 3.13%
|
|
|
Journal of Clinical Medicine
1 publication, 3.13%
|
|
|
Protein and Peptide Letters
1 publication, 3.13%
|
|
|
Cancer Drug Resistance
1 publication, 3.13%
|
|
|
Environmental Toxicology
1 publication, 3.13%
|
|
|
npj Systems Biology and Applications
1 publication, 3.13%
|
|
|
Neurological Research
1 publication, 3.13%
|
|
|
Communications Medicine
1 publication, 3.13%
|
|
|
Journal of Chemical Information and Modeling
1 publication, 3.13%
|
|
|
Journal of Biomedical Informatics
1 publication, 3.13%
|
|
|
Oncologie
1 publication, 3.13%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Springer Nature
7 publications, 21.88%
|
|
|
Elsevier
7 publications, 21.88%
|
|
|
MDPI
3 publications, 9.38%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 6.25%
|
|
|
Frontiers Media S.A.
2 publications, 6.25%
|
|
|
Wiley
2 publications, 6.25%
|
|
|
Taylor & Francis
2 publications, 6.25%
|
|
|
Hindawi Limited
1 publication, 3.13%
|
|
|
AME Publishing Company
1 publication, 3.13%
|
|
|
OAE Publishing Inc.
1 publication, 3.13%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 3.13%
|
|
|
American Chemical Society (ACS)
1 publication, 3.13%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 3.13%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
32
Total citations:
32
Citations from 2024:
11
(34.38%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Latha N. R. et al. Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy // Critical Reviews in Oncology/Hematology. 2020. Vol. 151. p. 102964.
GOST all authors (up to 50)
Copy
Latha N. R., Rajan A., Nadhan R., Achyutuni S., Sengodan S. K., Hemalatha S. K., Varghese G. R., Thankappan R., Krishnan N., Patra D., Warrier A., Srinivas P. Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy // Critical Reviews in Oncology/Hematology. 2020. Vol. 151. p. 102964.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.critrevonc.2020.102964
UR - https://doi.org/10.1016/j.critrevonc.2020.102964
TI - Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy
T2 - Critical Reviews in Oncology/Hematology
AU - Latha, Neetha Rajan
AU - Rajan, Arathi
AU - Nadhan, Revathy
AU - Achyutuni, Sarada
AU - Sengodan, Satheesh Kumar
AU - Hemalatha, Sreelatha Krishnakumar
AU - Varghese, Geetu Rose
AU - Thankappan, Ratheeshkumar
AU - Krishnan, Neethu
AU - Patra, Dipyaman
AU - Warrier, Arathy
AU - Srinivas, Priya
PY - 2020
DA - 2020/07/01
PB - Elsevier
SP - 102964
VL - 151
PMID - 32464482
SN - 1040-8428
SN - 1879-0461
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Latha,
author = {Neetha Rajan Latha and Arathi Rajan and Revathy Nadhan and Sarada Achyutuni and Satheesh Kumar Sengodan and Sreelatha Krishnakumar Hemalatha and Geetu Rose Varghese and Ratheeshkumar Thankappan and Neethu Krishnan and Dipyaman Patra and Arathy Warrier and Priya Srinivas},
title = {Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy},
journal = {Critical Reviews in Oncology/Hematology},
year = {2020},
volume = {151},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016/j.critrevonc.2020.102964},
pages = {102964},
doi = {10.1016/j.critrevonc.2020.102964}
}